>
Switch to:

Creative Medical Technology Holdings Cash-to-Debt

: 0.72 (As of Jun. 2021)
View and export this data going back to 2009. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Creative Medical Technology Holdings's cash to debt ratio for the quarter that ended in Jun. 2021 was 0.72.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Creative Medical Technology Holdings couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2021.

The historical rank and industry rank for Creative Medical Technology Holdings's Cash-to-Debt or its related term are showing as below:

OTCPK:CELZ' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01   Med: 0.19   Max: No Debt
Current: 0.72

0.01
No Debt

During the past 13 years, Creative Medical Technology Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 0.01. And the median was 0.19.

OTCPK:CELZ's Cash-to-Debt is ranked lower than
99.99% of the 319 Companies
in the Biotechnology industry.

( Industry Median: 10.28 vs. OTCPK:CELZ: 0.72 )

Creative Medical Technology Holdings Cash-to-Debt Historical Data

The historical data trend for Creative Medical Technology Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creative Medical Technology Holdings Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Cash-to-Debt
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.73 0.03 0.45 0.08 0.12

Creative Medical Technology Holdings Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Cash-to-Debt Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.12 0.84 0.72

Competitive Comparison

For the Biotechnology subindustry, Creative Medical Technology Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Creative Medical Technology Holdings Cash-to-Debt Distribution

For the Biotechnology industry and Healthcare sector, Creative Medical Technology Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Creative Medical Technology Holdings's Cash-to-Debt falls into.



Creative Medical Technology Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Creative Medical Technology Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2020 is calculated as:

Creative Medical Technology Holdings's Cash to Debt Ratio for the quarter that ended in Jun. 2021 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creative Medical Technology Holdings  (OTCPK:CELZ) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Creative Medical Technology Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Creative Medical Technology Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Creative Medical Technology Holdings Business Description

Creative Medical Technology Holdings logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
N/A
Address
211 E Osborn Road, Phoenix, AZ, USA, 85012
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Executives
Ichim Thomas director 2027 E. CEDAR ST. TEMPE AZ 85281

Creative Medical Technology Holdings Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)